Omada Health, Inc. Common Stock OMDA
HEALTHCARE · HEALTH INFORMATION SERVICESi
Market dataready · fetched 2026-11-12T02:45:57.020Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:06.407454008Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:45:56.649890+00:00
Omada Health, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 21.47 | 215.6% | 44.1% | |||
| 25Δ | 17.38 | 108.3% | 16.4% | |||
| 30Δ | 17.02 | 105.3% | 14.6% | |||
| 35Δ | 16.65 | 102.3% | 12.8% | |||
| 40Δ | 16.28 | 99.4% | 11.1% | |||
| 45Δ | 15.92 | 96.4% | 9.3% | 15.25 | 69.3% | 4.6% |
| 50Δ | 15.55 | 93.4% | 7.5% | 15.60 | 74.9% | 4.2% |
| 55Δ | 15.19 | 90.5% | 5.7% | 15.95 | 80.5% | 3.7% |
| 60Δ | 14.78 | 92.6% | 4.6% | 16.29 | 86.1% | 3.3% |
| 65Δ | 14.34 | 99.9% | 4.0% | 16.64 | 91.7% | 2.9% |
| 70Δ | 13.90 | 107.3% | 3.5% | 16.99 | 97.2% | 2.5% |
| 75Δ | 13.46 | 114.6% | 2.9% | 17.34 | 102.8% | 2.1% |
| 80Δ | 13.02 | 121.9% | 2.4% | 18.43 | 123.2% | 1.8% |
20Δ
- Pseudo strike
- 21.47
- IV
- 215.6%
- B/E move
- 44.1%
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- 17.38
- IV
- 108.3%
- B/E move
- 16.4%
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 17.02
- IV
- 105.3%
- B/E move
- 14.6%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 16.65
- IV
- 102.3%
- B/E move
- 12.8%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 16.28
- IV
- 99.4%
- B/E move
- 11.1%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 15.92
- IV
- 96.4%
- B/E move
- 9.3%
- Pseudo strike
- 15.25
- IV
- 69.3%
- B/E move
- 4.6%
50Δ
- Pseudo strike
- 15.55
- IV
- 93.4%
- B/E move
- 7.5%
- Pseudo strike
- 15.60
- IV
- 74.9%
- B/E move
- 4.2%
55Δ
- Pseudo strike
- 15.19
- IV
- 90.5%
- B/E move
- 5.7%
- Pseudo strike
- 15.95
- IV
- 80.5%
- B/E move
- 3.7%
60Δ
- Pseudo strike
- 14.78
- IV
- 92.6%
- B/E move
- 4.6%
- Pseudo strike
- 16.29
- IV
- 86.1%
- B/E move
- 3.3%
65Δ
- Pseudo strike
- 14.34
- IV
- 99.9%
- B/E move
- 4.0%
- Pseudo strike
- 16.64
- IV
- 91.7%
- B/E move
- 2.9%
70Δ
- Pseudo strike
- 13.90
- IV
- 107.3%
- B/E move
- 3.5%
- Pseudo strike
- 16.99
- IV
- 97.2%
- B/E move
- 2.5%
75Δ
- Pseudo strike
- 13.46
- IV
- 114.6%
- B/E move
- 2.9%
- Pseudo strike
- 17.34
- IV
- 102.8%
- B/E move
- 2.1%
80Δ
- Pseudo strike
- 13.02
- IV
- 121.9%
- B/E move
- 2.4%
- Pseudo strike
- 18.43
- IV
- 123.2%
- B/E move
- 1.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 73.94% | |
| 71.93% | |
| 68.11% | |
| 70.58% | |
| 71.41% | |
| 68.64% | |
| 74.25% | |
| 75.36% | |
| 77.43% | |
| 74.68% |
Health Information Services
OPRX
OptimizeRx Corporation is a digital health company providing communications solutions for life sciences companies, physicians, and patients. The company is headquartered in…
More →PHR
Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh,…
More →PRVA
Description unavailable
More →SDGR
Description unavailable
More →SOPH
Sophia Genetics SA (SOPH) stands at the forefront of data-driven medicine, delivering advanced genomic and clinical data analytics that significantly enhance patient outcomes.…
More →SPOK
Spok Holdings, Inc., through its subsidiary, Spok, Inc., provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East.…
More →